BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25550566)

  • 1. CT-guided brachytherapy as salvage therapy for intrahepatic recurrence of HCC after surgical resection.
    Schnapauff D; Collettini F; Hartwig K; Wieners G; Chopra S; Hamm B; Gebauer B
    Anticancer Res; 2015 Jan; 35(1):319-23. PubMed ID: 25550566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT).
    Collettini F; Lutter A; Schnapauff D; Hildebrandt B; Puhl G; Denecke T; Wust P; Gebauer B
    Rofo; 2014 Jun; 186(6):606-12. PubMed ID: 24407711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computed tomography-guided interstitial HDR brachytherapy (CT-HDRBT) of the liver in patients with irresectable intrahepatic cholangiocarcinoma.
    Schnapauff D; Denecke T; Grieser C; Collettini F; Seehofer D; Sinn M; Banzer J; Lopez-Hänninen E; Hamm B; Wust P; Gebauer B
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):581-7. PubMed ID: 21833806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of metastases adjacent to the liver hilum.
    Collettini F; Singh A; Schnapauff D; Powerski MJ; Denecke T; Wust P; Hamm B; Gebauer B
    Eur J Radiol; 2013 Oct; 82(10):e509-14. PubMed ID: 23791521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT-guided high-dose-rate brachytherapy of unresectable hepatocellular carcinoma.
    Collettini F; Schreiber N; Schnapauff D; Denecke T; Wust P; Schott E; Hamm B; Gebauer B
    Strahlenther Onkol; 2015 May; 191(5):405-12. PubMed ID: 25404063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT-guided high-dose-rate brachytherapy in the interdisciplinary treatment of patients with liver metastases of pancreatic cancer.
    Wieners G; Schippers AC; Collettini F; Schnapauff D; Hamm B; Wust P; Riess H; Gebauer B
    Hepatobiliary Pancreat Dis Int; 2015 Oct; 14(5):530-8. PubMed ID: 26459730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary experience with CT-guided high-dose rate brachytherapy as an alternative treatment for hepatic recurrence of cholangiocarcinoma.
    Kamphues C; Seehofer D; Collettini F; Bahra M; Neuhaus P; Wust P; Denecke T; Gebauer B; Schnapauff D
    HPB (Oxford); 2012 Dec; 14(12):791-7. PubMed ID: 23134179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of large (5-7 cm) and very large (>7 cm) tumours.
    Collettini F; Schnapauff D; Poellinger A; Denecke T; Schott E; Berg T; Wust P; Hamm B; Gebauer B
    Eur Radiol; 2012 May; 22(5):1101-9. PubMed ID: 22173693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous computed tomography-guided high-dose-rate brachytherapy ablation of breast cancer liver metastases: initial experience with 80 lesions.
    Collettini F; Golenia M; Schnapauff D; Poellinger A; Denecke T; Wust P; Riess H; Hamm B; Gebauer B
    J Vasc Interv Radiol; 2012 May; 23(5):618-26. PubMed ID: 22525020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computed tomography follow-up for the detection of hepatocellular carcinoma recurrence after initial radiofrequency ablation: a single-center experience.
    Mikami S; Tateishi R; Akahane M; Asaoka Y; Kondo Y; Goto T; Shiina S; Yoshida H; Koike K
    J Vasc Interv Radiol; 2012 Oct; 23(10):1269-75. PubMed ID: 22999746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival.
    Mohnike K; Wieners G; Schwartz F; Seidensticker M; Pech M; Ruehl R; Wust P; Lopez-Hänninen E; Gademann G; Peters N; Berg T; Malfertheiner P; Ricke J
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):172-9. PubMed ID: 20056348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstitial Brachytherapy in Combination With Previous Transarterial Embolization in Patients With Unresectable Hepatocellular Carcinoma.
    Schnapauff D; Tegel BR; Powerski MJ; Colletini F; Hamm B; Gebauer B
    Anticancer Res; 2019 Mar; 39(3):1329-1336. PubMed ID: 30842165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Percutaneous CT-guided high-dose brachytherapy (CT-HDRBT) ablation of primary and metastatic lung tumors in nonsurgical candidates].
    Collettini F; Schnapauff D; Poellinger A; Denecke T; Banzer J; Golenia MJ; Wust P; Gebauer B
    Rofo; 2012 Apr; 184(4):316-23. PubMed ID: 22297915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity-based cost analysis of hepatic tumor ablation using CT-guided high-dose rate brachytherapy or CT-guided radiofrequency ablation in hepatocellular carcinoma.
    Schnapauff D; Collettini F; Steffen I; Wieners G; Hamm B; Gebauer B; Maurer MH
    Radiat Oncol; 2016 Feb; 11():26. PubMed ID: 26911437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computed tomography-guided iodine-125 brachytherapy for unresectable hepatocellular carcinoma.
    Song Z; Ye J; Wang Y; Li Y; Wang W
    J Cancer Res Ther; 2019; 15(7):1553-1560. PubMed ID: 31939437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT-guided radiofrequency ablation after with transarterial chemoembolization in treating unresectable hepatocellular carcinoma with long overall survival improvement.
    Zhao M; Wang JP; Pan CC; Li W; Huang ZL; Zhang L; Fang WJ; Jiang Y; Li XS; Wu PH
    Eur J Radiol; 2012 Oct; 81(10):2717-25. PubMed ID: 22245655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique.
    Ricke J; Wust P; Stohlmann A; Beck A; Cho CH; Pech M; Wieners G; Spors B; Werk M; Rosner C; Hänninen EL; Felix R
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1496-505. PubMed ID: 15050329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter arterial chemoembolization with an interventional-CT system for recurrent hepatocellular carcinoma after living donor liver transplantation.
    Yamagami T; Yoshimatsu R; Ishikawa M; Kajiwara K; Aikata H; Tashiro H; Kakizawa H; Toyoda N; Ohdan H; Awai K
    Hepatogastroenterology; 2014; 61(133):1387-92. PubMed ID: 25436316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation.
    Ricke J; Wust P; Wieners G; Beck A; Cho CH; Seidensticker M; Pech M; Werk M; Rosner C; Hänninen EL; Freund T; Felix R
    J Vasc Interv Radiol; 2004 Nov; 15(11):1279-86. PubMed ID: 15525748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy.
    Ricke J; Mohnike K; Pech M; Seidensticker M; Rühl R; Wieners G; Gaffke G; Kropf S; Felix R; Wust P
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):479-85. PubMed ID: 20304566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.